Vaccine Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook (2026-2035)

The vaccine market was valued at USD 75.22 Billion in 2025. It is poised to grow at a CAGR of 10.50% during the forecast period of 2026-2035, and reach USD 204.15 Billion by 2035. The market growth is driven by rising infectious disease burden, expanding immunization programs, increasing government initiatives, growing awareness of preventive healthcare, and continuous advancements in vaccine technologies globally.

Key Market Trends and Insights

• By route of administration, the parenteral segment is expected to lead the market with a share of over 84% in the historical period.
• By age group, the adult vaccines segment is expected to lead the market with a share of above 56% in the historical period.
• North America is expected to dominate the global market with a share of about 39% in the historical period.

Market Size and Forecast

• Market Size (2025): USD 75.22 Billion
• Projected Market Size (2035): USD 204.15 Billion
• CAGR (2026-2035): 10.50%

Vaccine Market Overview

The market is driven by rising infectious disease prevalence, expanding immunization programs, and increasing awareness of preventive healthcare. Government initiatives and global vaccination campaigns support sustained demand. Technological advancements, including mRNA and recombinant platforms, are enhancing vaccine efficacy and production efficiency. Strong investments and partnerships continue to expand access, supporting consistent growth across developed and emerging healthcare markets worldwide. The market reached a value of approximately USD 75.22 Billion in 2025.

Vaccine Market Growth Drivers

Advanced mRNA Vaccine Development Driving the Market Demand

Increasing pandemic preparedness requirements and rising investment in next-generation vaccine technologies are key growth drivers. For instance, in April 2026, Moderna initiated a late-stage Phase III trial for its mRNA-based bird flu vaccine across the US and UK to evaluate efficacy against emerging strains. This advancement is expected to strengthen pandemic preparedness by accelerating innovative vaccine development and global response capabilities in the forecast period.

Vaccine Market Trends

Key trends shaping the market include increasing immunization coverage, advancements in vaccine technologies, expanding public-private partnerships, and rising focus on pandemic preparedness globally.

Global Vaccine Policy Strengthening the Market Expansion

Rising infectious disease burden and increasing government immunization initiatives are key market drivers. For instance, in February 2026, the World Health Organization emphasized expanded vaccination strategies and global immunization strengthening to reduce the impact worldwide. This development is expected to enhance the vaccination coverage by improving preventive healthcare systems and accelerating coordinated global immunization adoption in the forecast period.

Vaccine Market Segmentation

Market Breakup by Vaccine Type

• Conjugate Vaccines
• Inactivated Vaccines
• Live Attenuated Vaccines
• mRNA Vaccines
• Recombinant Vaccines
• Toxoid Vaccines
• Viral-Vector Vaccines
• Others

Market Breakup by Type

• Monovalent Vaccines
• Multivalent Vaccines

Market Breakup by Indication

• DTP
• Hepatitis
• Herpes Zoster
• HPV
• Influenza
• Meningococcal Disease
• MMR
• Pneumococcal Disease
• Polio
• Rotavirus
• RSV
• Others

Market Breakup by Route of Administration

• Oral
• Parenteral
• Others

Market Breakup by Age Group

• Adult Vaccines
• Pediatric Vaccines
• Others

Market Breakup by Distribution Channel

• Hospitals and Clinics
• Retail pharmacies
• Online Channels
• Government Suppliers

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Vaccine Market Share

Parenteral Likely to Dominate the Market Segment by Route of Administration

The parenteral segment likely accounted for approximately 84% of the market share in the historical period, supported by its widespread use in routine immunization programs and established efficacy. Strong healthcare infrastructure and clinical preference are further expected to reinforce its position. The segment is likely to dominate due to consistent demand patterns and reliable delivery mechanisms, strengthening overall vaccination uptake across global healthcare systems and preventive strategies.

Vaccine Market Analysis by Region

North America is expected to account for over 39% of the global share in the histrical period, supported by advanced healthcare infrastructure and strong immunization frameworks. High awareness levels and continuous investment in vaccine development sustain regional growth. The region is likely to dominate due to widespread adoption and government-backed programs, enhancing overall healthcare infrastructure across diverse population groups and improving vaccination accessibility.

Leading Players in the Vaccine Market

The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

AstraZeneca plc

Founded in 1999 and headquartered in Cambridge, United Kingdom, AstraZeneca plc is a global biopharmaceutical company. Its vaccine portfolio includes COVID-19 and respiratory immunization solutions developed through strategic collaborations. The company emphasizes innovation and large-scale manufacturing, supporting global immunization efforts and strengthening overall biopharmaceutical innovation across preventive healthcare systems worldwide.

Bavarian Nordic A/S

Established in 1994 and headquartered in Hellerup, Denmark, Bavarian Nordic A/S specializes in vaccine development for infectious diseases. Its portfolio includes vaccines for smallpox, mpox, and rabies. The company focuses on advanced immunization technologies and global supply expansion, enhancing vaccine developmentthrough strategic partnerships and government-supported programs globally.

Bharat Biotech Int’l Ltd

Founded in 1996 and headquartered in Hyderabad, India, Bharat Biotech Int’l Ltd is a leading vaccine manufacturer. Its portfolio includes vaccines for COVID-19, rotavirus, and cholera. The company emphasizes affordable innovation and global accessibility, strengthening immunization programs through scalable production and expanding presence in emerging and developed markets worldwide.

Biological E Ltd

Established in 1953 and headquartered in Hyderabad, India, Biological E Ltd is a prominent vaccine producer. Its portfolio includes pediatric vaccines and COVID-19 immunization solutions. The company focuses on expanding manufacturing capabilities and global distribution, supporting public health initiatives through partnerships with international organizations and government immunization programs globally.

Other key players in the market are CSL Seqirus, Daiichi Sankyo Co. Ltd, Merck & Co., Inc, Emergent BioSolutions, GlaxoSmithKline plc, and Johnson & Johnson.

Key Questions Answered in the Vaccine Market Report

• What was the vaccine market value in 2025?
• What is the vaccine market forecast outlook for 2026-2035?
• What major factors aid the demand for vaccine market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market’s major drivers, opportunities, and restraints?
• What are the major vaccine market trends?
• Which vaccine type is expected to dominate the market segment?
• Which type is likely to dominate the market segment?
• Which indication is anticipated to dominate the market segment?
• Which route of administration is expected to dominate the market segment?
• Which age group is likely to dominate the market segment?
• Which distribution channel is anticipated to dominate the market segment?
• Who are the key players in the vaccine market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?